SPRY Deferred Revenue

Ars Pharmaceuticals Inc · Deferred Revenue

SPRY logo

SPRY Deferred Revenue

Latest reported$609.00K
SPRY FY Deferred Revenue ($0.00 → $609.00K)
High-resolution chart · PNG

SPRY deferred revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ars Pharmaceuticals Inc Deferred Revenue — Annual fiscal periods (USD)
Period endingDeferred Revenue (USD)
609,000
557,000
0
0
1,457,000
3,518,000
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.